BioScrip Agrees To Pay $15M In FCA Kickback Suit
By Jeff Sistrunk · January 8, 2014, 6:52 PM EST
BioScrip Inc. has agreed to pay $15 million to exit a False Claims Act whistleblower suit alleging it received kickbacks from Novartis Pharmaceuticals Corp. to push patients to continue using Novartis'...
To view the full article, register now.